SYRS
Companies
NASDAQ
Syros Pharmaceuticals Inc.
Health Care
$0.03
-$0.20 (-87.17%)
Price Chart
Overview
About SYRS
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Market Cap
$137.7M
Volume
14.8K
Avg. Volume
1.3M
P/E Ratio
-0.009097744
Dividend Yield
0.00%
Employees
100.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.56
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SYRS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$137.7M
Volume14.8K
P/E Ratio-0.01
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
July 31, 2024Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025